Our governance, structure and management (continued)

Our Trustees 2010/11 The Trustees who served during the year and as at 27 June 2011 are listed below along with biographies.

Michael Pragnell MA (Oxon) MBA (INSEAD) Chairman Michael Pragnell (64) is a Non-executive Director of VINCI SA and a member of the Board of INSEAD. He was founder Chief Executive Officer of Syngenta AG, based in Switzerland, from its public listing in 2000 until his retirement at the end of 2007; he served as Chairman of the Executive Committee and a member of the Board. He was previously an Executive Director of AstraZeneca plc, a member of the Supervisory Board of Advanta BV, a Non-executive Director of David S Smith plc, a member of the Board of Courtaulds plc as CEO of Courtaulds Coatings and latterly CFO.

Professor Doctor Anton Berns PhD Professor Berns (66) is Director of Research and Chairman of the Board of Directors of the Netherlands Cancer Institute/ Anton van Leeuwenhoek Hospital. He is a member of the Royal Netherlands Academy of Arts and Sciences and Secretary General of the European Molecular Biology Organisation (EMBO). He sits on a number of scientific advisory boards including CNIO Madrid, Genomic Institute Singapore, IMP Vienna, WEHI Melbourne and European Institute of Oncology in Milan. He studied biochemistry at the University of Nijmegen, receiving his Masters (cum laude) in 1969 and his PhD in 1972. He did his postdoctoral training in the group of Rudolf Jaenisch at the Salk Institute in La Jolla, California, where he studied the role of retroviruses in causing lymphomas in mice.

Professor Adrian Bird CBE FRS FRSE Professor Bird (63) has held the Buchanan Chair of Genetics at the University of Edinburgh since 1990 and is Director of the Wellcome Trust Centre for Cell Biology at the University. His research concerns epigenetic control of gene expression by DNA methylation in health and disease. He previously served as Deputy Chairman of the Wellcome Trust (2007–2010), and is a Trustee of the Kirkhouse Trust and of the Rett Syndrome Research Trust. Awards include the Louis-Jeantet Prize for Medicine and the Charles Léopold Mayer Prize of the French Academy of Sciences.

Professor Colin Bird CBE FRSE Professor Bird (73) is a Fellow of the Royal Colleges of Pathologists, Physicians and Surgeons and of the Academy of Medical Sciences and the Royal Society of Edinburgh. He was Chairman and Trustee/Director of onCoreUK until 2011. He was formerly Dean of Medicine and Provost of Medicine and Veterinary Medicine at Edinburgh University from 1975–2002 and Professor of Pathology at Leeds (1975–1986) and Edinburgh (1986–2002) universities. He has longstanding interests in cancer research, both basic and clinical aspects, and has worked on these in several universities and research institutes in the UK and USA.

Dr Philip Campbell BSc MSc DSc FInstP FRAS Dr Campbell (60) is Editor-in-Chief of Nature and of Nature publications. He is a Fellow of the Institute of Physics and a Fellow of the Royal Astronomical Society. He took up his present position in December 1995 and is also a member of the Board of Directors of the Nature Publishing Group. He has advised or collaborated with the Wellcome Trust, US National Institutes of Health, the UK Office of Science and Technology and the European Commission on aspects of the life sciences and their impacts in society.

Sir James Crosby BA FFA Sir James (55) is Chairman of Misys plc and the Senior Independent Director of Compass Group plc. He is a member of the European Advisory Board of Bridgepoint Capital and a member of the Finance Committee of the Delegacy of Oxford University Press. He previously served as a Non-executive Director of ITV (2003–2009) and the Financial Services Authority (2004–2009) following a 30-year executive career in fund management, insurance and banking, before retiring from HBOS in 2006.

Liz Hewitt FCA BSc(Econ) FRSA Liz Hewitt was Group Director of Corporate Affairs for Smith & Nephew plc, the global medical technology business, from 2004 to 2011. Liz is a Fellow of the Institute of Chartered Accountants in England and Wales, having qualified with Arthur Andersen & Co. She has worked in the venture capital industry for Gartmore Investment Limited, Citicorp Venture Capital Limited and 3i Group plc. She has had non-executive roles with the Rail Users Consultative Committee, Bournewood NHS Trust, the Audit and Finance Committee of the Royal Society of Arts, and was Vice-Chairman of the Surrey Police Authority.

20 / Annual Report and Accounts / Our governance, structure and management